Newsroom

Newsroom

Medicine image.

Press Release

March 3, 2020
CD&R has reached agreement with the board of Huntsworth plc on the terms of a recommended cash offer for the entire issued and to be issued share capital of Huntsworth. To read the announcement and other relevant documentation, please visit www....
Medicine image.

Press Release

March 3, 2020
CD&R has reached agreement with the board of Huntsworth plc on the terms of a recommended cash offer for the entire issued and to be issued share capital of Huntsworth. To read the announcement and other relevant documentation, please visit www....
John F. Welch

Press Release

March 2, 2020
Jack was a beloved member of CD&R for nearly 20 years. It is hard for us to imagine that he will not be with us to push, prod, challenge, joke, and, above all, set the highest possible standards for each of us, our portfolio company executives,...
INSEAD Global Private Equity Initiative

Press Release

February 4, 2020
INSEAD’s Global Private Equity Initiative (GPEI) (“INSEAD”) today announced the release of new research on family-backed enterprises. The Institutionalization of Family Firms, Europe examines how institutionalization can help European family-owned...
State of the Market 2020: An Article on Partnership Investing by Christian Rochat

Perspectives

January 22, 2020
Christian Rochat discusses Partnership investing in Evercore's 2020 State of the Market report.  
Philippe Oursel photograph.

Perspectives

January 16, 2020
Many years from now, if archeologists were to discover newspaper headlines covering today’s torrid deal environment, they might mistake it for a horse race. Company A has the pole position; Company B is in the lead; Company C may be gaining ground....
Mr Harsh photo.

Press Release

January 15, 2020
Clayton, Dubilier & Rice announced today that it has appointed Harsh Agarwal as a Principal on its investment team. Mr. Agarwal, who is based in the Firm’s New York office, is principally engaged in evaluating and executing investments in the...
Jeff Hawn Photo

Press Release

January 9, 2020
Clayton, Dubilier & Rice today announced the appointment of Jeff Hawn, former Chairman and Chief Executive Officer of Quest Software, as a Partner at the Firm. Mr. Hawn has 20 years’ experience across a range of senior executive roles in...
SOCOTEC logo

Press Release

December 16, 2019
The SOCOTEC group, one of Europe’s largest providers of testing, inspection and certification services for construction and infrastructure sites, today announced the acquisition of DPA (“David Pattillo & Associates”), a highly respected provider...
Cynosure-Logo.

Press Release

November 20, 2019
Clayton, Dubilier & Rice today announced an agreement under which CD&R-managed funds will acquire Cynosure, LLC, a leader in medical aesthetics systems and technologies, from Hologic, Inc. (NASDAQ:HOLX). Cynosure develops, manufactures, and...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...

Events

December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
Screen shot from video
Play Video

Events

December 7, 2021
CD&R Chairman Don Gogel discusses trends and opportunities in private capital with Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC) at London Business School. The video below...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.